Details of the Drug | DrugMAP

General Information of Drug (ID: DMUTCDY)

Drug Name

MER-101

Synonyms

Zoledronic acid oral

Indication

Disease Entry	ICD 11	Status	REF
Bone metastases	2D50	Phase 2	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

Chemical Identifiers

Formula: C5H12N2O8P2
Canonical SMILES: C1=CN(C=N1)CC(O)(P(=O)(O)O)P(=O)(O)O.O
InChI: 1S/C5H10N2O7P2.H2O/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7;/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14);1H2
InChIKey: FUXFIVRTGHOMSO-UHFFFAOYSA-N

Cross-matching ID

PubChem CID: 121586
CAS Number: 165800-06-6
TTD ID: D0O0LC

References

1	ClinicalTrials.gov (NCT00636740) Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients. U.S. National Institutes of Health.